Label: DRX CHOICE FIBER THERAPY- methylcellulose tablet
- NDC Code(s): 68163-122-00
- Packager: RARITAN PHARMACEUTICALS INC
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: OTC monograph not final
DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Drug Label Information
Updated September 2, 2023
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each caplet)
- Purpose
-
Uses
- ▪
- relieves occasional constipation (irregularity)
- ▪
- generally produces a bowel movement in 12 -72 hours.
Warnings
Choking: Taking this product without adequate fluid may cause it to swell and block your throat or esophagus and may cause choking .Do not take this product if you have difficulty in swallowing. If you experience chest pain, vomiting or difficulty in swallowing or breathing after taking this product, seek immediate medical attention.
-
Directions
Take this product (child or adult dose) with at least 8 ounces (a full glass) of water or other fluid.
- •
- Taking this product without enough liquid may cause choking.
- See choking warning.
Age
Dose
Maximum Dose
adults & children 12 years of age and over
start with 2 caplets. Increase as needed up to 6 times per day.
Do not exceed 12 caplets per day
Children 6-11 years of age
Start with 1 caplet. Increase as needed up to 6 times per day
Do not exceed 6 caplets per day
children under 6 years of age
Consult a physician
Consult a physician
- Other information
- Inactive ingredients
- Questions or comments?
-
Principal Display Panel
DRx Choice®
NDC 68163-122-00
Compare to the active Ingredients in Citrucel® Caplets *
Methylcellulose
Fiber Therapy
- NaN
- Gentle and clinically proven effective†
Manufactured by:
Raritan Pharmaceuticals
8 Joanna Court,
East Brunswick, NJ 08816
†When Used as Directed
††Based On Laboratory Testing. Individual Results May Vary.
*This product is not manufactured or distributed by GlaxoSmithKline, the owner of the registered trademark Citrucel® Caplets.
-
INGREDIENTS AND APPEARANCE
DRX CHOICE FIBER THERAPY
methylcellulose tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:68163-122 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength METHYLCELLULOSE (4000 MPA.S) (UNII: MRJ667KA5E) (METHYLCELLULOSE (4000 MPA.S) - UNII:MRJ667KA5E) METHYLCELLULOSE (4000 MPA.S) 500 mg Inactive Ingredients Ingredient Name Strength ADIPIC ACID (UNII: 76A0JE0FKJ) CALCIUM CARBONATE (UNII: H0G9379FGK) CROSPOVIDONE (120 .MU.M) (UNII: 68401960MK) FD&C YELLOW NO. 6 (UNII: H77VEI93A8) MAGNESIUM STEARATE (UNII: 70097M6I30) MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U) POLYSORBATE 80 (UNII: 6OZP39ZG8H) SILICON DIOXIDE (UNII: ETJ7Z6XBU4) Product Characteristics Color ORANGE (Light orange) Score no score Shape CAPSULE (Caplet) Size 19mm Flavor Imprint Code RP122 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:68163-122-00 100 in 1 BOTTLE; Type 0: Not a Combination Product 07/20/2022 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC monograph not final part334 07/20/2022 Labeler - RARITAN PHARMACEUTICALS INC (127602287)